Table of Content

1. Executive Summary
   1. Global Flu Vaccines Market Snapshot, 2025 and 2032
   2. Market Opportunity Assessment, 2025 – 2032, US$ Bn
   3. Key Market Trends
   4. Future Market Projections
   5. Premium Market Insights
   6. Industry Developments and Key Market Events
   7. PMR Analysis and Recommendations
2. Market Overview
   1. Market Scope and Definition
   2. Market Dynamics
      1. Drivers
      2. Restraints
      3. Opportunity
      4. Challenges
      5. Key Trends
   3. COVID-19 Impact Analysis
   4. Forecast Factors – Relevance and Impact
3. Value Added Insights
   1. Value Chain Analysis
   2. Product Adoption / Usage Analysis
   3. Key Market Players
   4. Key Promotional Strategies, By Key Players
   5. Regulatory Landscape
   6. PESTLE Analysis
   7. Porter’s Five Force Analysis
4. Price Trend Analysis, 2024
   1. Key Highlights
   2. Pricing Analysis, By Product
   3. Regional Prices and Product Preferences
5. Global Flu Vaccines Market Outlook
   1. Key Highlights
      1. Market Volume (Units) Projections
      2. Market Size (US$ Bn) and Y-o-Y Growth
      3. Absolute $ Opportunity
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast
      1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, 2019-2024
      2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, 2025–2032
   3. Global Flu Vaccines Market Outlook: Product
      1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Product, 2019-2024
      2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
         1. Trivalent Flu Vaccine
         2. Quadrivalent Flu Vaccine
      3. Market Attractiveness Analysis: Product
   4. Global Flu Vaccines Market Outlook: Dosage Form
      1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Dosage Form, 2019-2024
      2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
         1. Intramuscular Injection
         2. Nasal Spray
         3. Intradermal Shot  
      3. Market Attractiveness Analysis: Dosage Form
   5. Global Flu Vaccines Market Outlook: Distribution Channel
      1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Distribution Channel, 2019-2024
      2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
         1. Institutional Sales
            1. Hospitals
            2. Community Clinics
            3. Public Health Agencies
            4. Workplace Purchasing
         2. Retail Sales
            1. Retail Pharmacies
            2. Mail Order Pharmacies
      3. Market Attractiveness Analysis: Distribution Channel
6. Global Flu Vaccines Market Outlook: Region
   1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Region, 2019-2024
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Region, 2025–2032
      1. North America
      2. Latin America
      3. Europe
      4. East Asia
      5. South Asia and Oceania
      6. Middle East & Africa
   3. Market Attractiveness Analysis: Region
7. North America Flu Vaccines Market Outlook
   1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Dosage Form
      4. By Distribution Channel
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
      1. U.S.
      2. Canada
   3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
      1. Trivalent Flu Vaccine
      2. Quadrivalent Flu Vaccine   
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
      1. Intramuscular Injection
      2. Nasal Spray
      3. Intradermal Shot
   5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
      1. Institutional Sales
         1. Hospitals
         2. Community Clinics
         3. Public Health Agencies
         4. Workplace Purchasing
      2. Retail Sales
         1. Retail Pharmacies
         2. Mail Order Pharmacies
   6. Market Attractiveness Analysis
8. Europe Flu Vaccines Market Outlook
   1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Dosage Form
      4. By Distribution Channel
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
      1. Germany
      2. France
      3. U.K.
      4. Italy
      5. Spain
      6. Russia
      7. Rest of Europe
   3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
      1. Trivalent Flu Vaccine
      2. Quadrivalent Flu Vaccine  
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
      1. Intramuscular Injection
      2. Nasal Spray
      3. Intradermal Shot
   5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
      1. Institutional Sales
         1. Hospitals
         2. Community Clinics
         3. Public Health Agencies
         4. Workplace Purchasing
      2. Retail Sales
         1. Retail Pharmacies
         2. Mail Order Pharmacies
   6. Market Attractiveness Analysis
9. East Asia Flu Vaccines Market Outlook
   1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
      1. By Country
      2. By Product
      3. By Dosage Form
      4. By Distribution Channel
   2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
      1. China
      2. Japan
      3. South Korea
   3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
      1. Trivalent Flu Vaccine
      2. Quadrivalent Flu Vaccine  
   4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
      1. Intramuscular Injection
      2. Nasal Spray
      3. Intradermal Shot
   5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
      1. Institutional Sales
         1. Hospitals
         2. Community Clinics
         3. Public Health Agencies
         4. Workplace Purchasing
      2. Retail Sales
         1. Retail Pharmacies
         2. Mail Order Pharmacies
   6. Market Attractiveness Analysis
10. South Asia & Oceania Flu Vaccines Market Outlook
    1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product
       3. By Dosage Form
       4. By Distribution Channel
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
       1. India
       2. Indonesia
       3. Thailand
       4. Singapore
       5. ANZ
       6. Rest of South Asia & Oceania
    3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
       1. Trivalent Flu Vaccine
       2. Quadrivalent Flu Vaccine  
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
       1. Intramuscular Injection
       2. Nasal Spray
       3. Intradermal Shot
    5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
       1. Institutional Sales
          1. Hospitals
          2. Community Clinics
          3. Public Health Agencies
          4. Workplace Purchasing
       2. Retail Sales
          1. Retail Pharmacies
          2. Mail Order Pharmacies
    6. Market Attractiveness Analysis
11. Latin America Flu Vaccines Market Outlook
    1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product
       3. By Dosage Form
       4. By Distribution Channel
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
       1. Brazil
       2. Mexico
       3. Rest of Latin America
    3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
       1. Trivalent Flu Vaccine
       2. Quadrivalent Flu Vaccine  
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
       1. Intramuscular Injection
       2. Nasal Spray
       3. Intradermal Shot
    5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
       1. Institutional Sales
          1. Hospitals
          2. Community Clinics
          3. Public Health Agencies
          4. Workplace Purchasing
       2. Retail Sales
          1. Retail Pharmacies
          2. Mail Order Pharmacies
    6. Market Attractiveness Analysis
12. Middle East & Africa Flu Vaccines Market Outlook
    1. Historical Market Size (US$ Bn) and Volume (Units) Analysis, By Market, 2019-2024
       1. By Country
       2. By Product
       3. By Dosage Form
       4. By Distribution Channel
    2. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast by Country, 2025–2032
       1. GCC Countries
       2. Egypt
       3. South Africa
       4. Northern Africa
       5. Rest of Middle East & Africa
    3. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Product, 2025–2032
       1. Trivalent Flu Vaccine
       2. Quadrivalent Flu Vaccine  
    4. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Dosage Form, 2025–2032
       1. Intramuscular Injection
       2. Nasal Spray
       3. Intradermal Shot
    5. Market Size (US$ Bn) and Volume (Units) Analysis and Forecast, By Distribution Channel, 2025–2032
       1. Institutional Sales
          1. Hospitals
          2. Community Clinics
          3. Public Health Agencies
          4. Workplace Purchasing
       2. Retail Sales
          1. Retail Pharmacies
          2. Mail Order Pharmacies
    6. Market Attractiveness Analysis
13. Competition Landscape
    1. Market Share Analysis, 2024
    2. Market Structure
       1. Competition Intensity Mapping by Market
       2. Competition Dashboard
    3. Company Profiles (Details – Overview, Financials, Strategy, Recent Developments)
       1. Sanofi Pasteur
          1. Overview
          2. Segments and End Users
          3. Key Financials
          4. Market Developments
          5. Market Strategy
       2. AstraZeneca
       3. Csl Ltd.
       4. Abbott
       5. GlaxoSmithKline Plc.
       6. Serum Institute of India Pvt.Ltd
       7. Daiichi Sankyo
       8. Sinovac Biotech
       9. Bharat Biotech
       10. Serum Institute of India
       11. Biondvax Pharmaceuticals
       12. Valneva SE
       13. Others
14. Appendix
    1. Research Methodology
    2. Research Assumptions
    3. Acronyms and Abbreviations